Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients
- PMID: 32768698
- PMCID: PMC7406426
- DOI: 10.1016/j.ijid.2020.07.079
Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients
Comment on
-
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.Int J Infect Dis. 2020 Aug;97:396-403. doi: 10.1016/j.ijid.2020.06.099. Epub 2020 Jul 2. Int J Infect Dis. 2020. PMID: 32623082 Free PMC article.
References
-
- Arshad S., Kilgore P., Chaudhry Z.S., Jacobsen G., Wang D.D., Huitsing K. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. Int J Infect Dis. 2020 doi: 10.1016/j.ijid.2020.06.099. [Published online ahead of print, 2 July 2020]. S1201-9712(20)30534-30538. - DOI - PMC - PubMed
-
- Horby P., Lim W.S., Emberson J., Mafham M., Bell J., Linsell L. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv. 2020 doi: 10.1101/2020.06.22.20137273. 06.22.20137273. - DOI
-
- Imai K., King G., Stuart E.A. Misunderstandings between experimentalists and observationalists about causal inference. J R Stat Soc. 2008;171:481–502.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources